Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 14 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00975195Phase 4Results posted
• The Effect on Depressive Symptoms in ECF Residents With COPDCompletedNCT00974246Phase 4Results posted
• Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00974220Not applicableResults posted
• Oral Cyclosporine in Chronic Obstructive Pulmonary DiseaseCompletedNCT00974142Phase 1/2Results posted
• Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)CompletedNCT00970268Phase 3Results posted
• Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00958919Not applicableResults posted
• GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary DiseaseCompletedNCT00950807Phase 2Results posted
• A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With TiotropiumCompletedNCT00949975Phase 2Results posted
• The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00939211Phase 2Results posted
• Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00932646Phase 3Results posted
• Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00931385Phase 3Results posted
• Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00929734Phase 2Results posted
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00929110Phase 3Results posted
• Actuation Indicator Trial in Patients With COPDCompletedNCT00928746Phase 3Results posted
• To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00917150Phase 2Results posted
• Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00914810Phase 3Results posted
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00909779Phase 3Results posted
• A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00900731Phase 3Results posted
• Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)CompletedNCT00891462Phase 3Results posted
• Effect of Oxygen-supply on 6-Minute-Walking-Distance of COPD III/IV-patientsCompletedNCT00886639Not applicableResults posted
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00877383Phase 3Results posted
• Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00876694Phase 3Results posted
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With EmphysemaTerminatedNCT00874497Phase 2Results posted
• The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00870896Early Phase 1Results posted
• Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00868231Phase 2Results posted
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00862641Phase 4Results posted
• A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00857766Phase 4Results posted
• A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00856193Phase 2Results posted
• BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPDCompletedNCT00846768Phase 2Results posted
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00846586Phase 3Results posted
• Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRICompletedNCT00846287Not applicableResults posted
• Exacerbation StudyCompletedNCT00845728Phase 3Results posted
• Effect of Inhaled Steroids on Gene Expression in the Lungs - 2TerminatedNCT00826748Phase 4Results posted
• Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPDCompletedNCT00824382Phase 2Results posted
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00821093Phase 3Results posted
• ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPDCompletedNCT00801684Phase 2Results posted
• Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease IICompletedNCT00796653Phase 3Results posted
• Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00794157Phase 3Results posted
• Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease ICompletedNCT00793624Phase 3Results posted
• Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00792805Phase 3Results posted
• Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator MonotherapyCompletedNCT00791518Results posted
• TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot TrialCompletedNCT00789997Phase 2/3Results posted
• A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00784550Phase 4Results posted
• Outlook Quality of Life InterventionCompletedNCT00784095Not applicableResults posted
• 12 / 48 wk Pivotal PFT vs PBO in COPD IICompletedNCT00782509Phase 3Results posted
• 12 / 48 Week Pivotal PFT vs PBO in COPD ICompletedNCT00782210Phase 3Results posted
• 14729-D9831C00002- 1 Month Biopsy StudyCompletedNCT00766415Phase 2Results posted
• Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)TerminatedNCT00763035Early Phase 1Results posted
• A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00758706Phase 2Results posted
• Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00758459Phase 2Results posted
• Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPDCompletedNCT00754546Phase 4Results posted
• Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPDCompletedNCT00749411Phase 2Results posted
• Reproducibility of 6 Minute Walk Tests for Oxygen DesaturationCompletedNCT00740220Results posted
• A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00739648Phase 2Results posted
• Comparison of Repetitive Magnetic Stimulation and Exercise on Quadriceps Function in COPDCompletedNCT00737698Not applicableResults posted
• A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysCompletedNCT00732472Phase 2Results posted
• A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00731822Phase 2Results posted
• Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00720499Phase 2Results posted
• Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00706914Phase 2Results posted
• A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00703391Phase 2Results posted
• Observational Non-Interventional Study With Spiriva Respimat in COPD PatientsCompletedNCT00699699Results posted
• SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00698828Phase 2Results posted
• Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)CompletedNCT00696020Phase 2Results posted
• Long-term Oxygen Treatment TrialCompletedNCT00692198Phase 3Results posted
• Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00690482Phase 2Results posted
• Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00680056Phase 4Results posted
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00677807Phase 3Results posted
• Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00677690Phase 3Results posted
• Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00676052Phase 2Results posted
• An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.CompletedNCT00674817Phase 2Results posted
• Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00669617Phase 3Results posted
• Tiotropium/Salmeterol Inhalation Powder in COPDTerminatedNCT00668772Phase 3Results posted
• Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPDCompletedNCT00662792Phase 3Results posted
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseTerminatedNCT00642616Phase 3Results posted
• Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.CompletedNCT00640315Phase 1Results posted
• Special Survey Long-term Treatment With Tiotropium on COPDCompletedNCT00638183Results posted
• Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation TrialCompletedNCT00637299Early Phase 1Results posted
• An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT00636961Phase 2Results posted
• Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT00633217Phase 4Results posted
• Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00629239Phase 2Results posted
• Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EUCompletedNCT00628862Phase 3Results posted
• Aclidinium/Formoterol Fixed Combination Dose Finding StudyCompletedNCT00626522Phase 2Results posted
• Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual PracticeCompletedNCT00624377Results posted
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00624286Phase 3Results posted
• A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00622635Phase 3Results posted
• Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease SeveritiesCompletedNCT00621582Results posted
• The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00620022Phase 3Results posted
• Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD GuidelinesCompletedNCT00615992Results posted
• A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active ControlCompletedNCT00615459Phase 3Results posted
• Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00615030Phase 3Results posted
• A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00606684Phase 2Results posted
• Chronic Obstructive Pulmonary Disease Markers and PrognosisCompletedNCT00605540Results posted
• Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary DiseaseCompletedNCT00595114Results posted
• Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory FailureTerminatedNCT00594009Not applicableResults posted
• Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00581945Phase 1/2Results posted
• Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of BronchodilationCompletedNCT00578968Phase 4Results posted
• Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPDCompletedNCT00571428Phase 4Results posted
• Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00570778Phase 2Results posted
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active ControlCompletedNCT00567996Phase 3Results posted
• Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.CompletedNCT00563381Phase 4Results posted

← Pulmonary Disease, Chronic Obstructive overview